| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/20/2011 | US20110015184 Vinyl-phenyl derivatives for inflammation and immune-related uses |
| 01/20/2011 | US20110015183 Substituted pyrazole sigma receptor antagonists |
| 01/20/2011 | US20110015175 Bicyclic Compounds for the Reduction of Beta-Amyloid Production |
| 01/20/2011 | US20110015165 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 01/20/2011 | US20110015157 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/20/2011 | US20110015136 humanized model of membrane attack complex (MAC) formation on murine retina and compositions, kits and methods for treatment of macular degeneration |
| 01/20/2011 | US20110015130 Polypeptides Selective for alphavbeta3 Integrin Conjugated With a Variant Of Human Serum Albumin (HSA) And Pharmaceutical Uses Thereof |
| 01/20/2011 | US20110015127 Targeting complement factor h for treatment of diseases |
| 01/20/2011 | US20110014294 Stimulation of ocular retrobulbar blood flow using ocular irritants |
| 01/20/2011 | US20110014276 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |
| 01/20/2011 | US20110014198 Anti-vegf antibodies |
| 01/20/2011 | US20110014194 Methods for inhibiting angiogenesis using egfl8 antagonists |
| 01/20/2011 | CA2768237A1 Treatment method |
| 01/20/2011 | CA2768169A1 Aminopyridine derivatives for the treatment of tumors and inflammatory diseases |
| 01/20/2011 | CA2767992A1 2 - [[[2 -[(hydroxyacetyl) amino]- 4 -pyridinyl] methyl] thio]- n -[4 - (trifluoromethoxy) phenyl]- 3 -pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof |
| 01/20/2011 | CA2738151A1 Eye drop with difluprednate for macular edema treatment |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275437A1 Polypeptide and pharmaceutical composition containing the polypeptide |
| 01/19/2011 | EP2275416A1 Biologically active methylene blue derivatives |
| 01/19/2011 | EP2275107A2 Combinations for the treatment of diseases involving cell proliferation |
| 01/19/2011 | EP2275102A1 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 01/19/2011 | EP2275099A1 Treatment of faecal incontinence with 1r,2s-methoxamine |
| 01/19/2011 | EP2274279A1 Nitric oxide donating prostamides |
| 01/19/2011 | EP2274006A2 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 01/19/2011 | EP2246327A9 A process for isolation of lutein and zeaxanthin crystals from plant sources |
| 01/19/2011 | EP1481969B1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2011 | EP1409008B1 Use of a nucleic acid molecule coding the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 01/19/2011 | CN201709412U Health and massage bra pad containing cassia seeds |
| 01/19/2011 | CN1950389B Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 01/19/2011 | CN101952280A Bicyclic heterocyclic derivative |
| 01/19/2011 | CN101952261A Substituted cyclopentanes having prostaglanding activity |
| 01/19/2011 | CN101951899A Abnormal intraocular pressure treatment |
| 01/19/2011 | CN101948539A IL-18 binding proteins |
| 01/19/2011 | CN101948439A Extraction method and application to medicine of active alkaloid compounds in cervus nippon temminck |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101948416A Compound used for treating metabolic disorder |
| 01/19/2011 | CN101948412A Site-15 deacetylation and site-13 straight-chain sulfamic acid substituted hypocrellin derivative, preparation method and application thereof |
| 01/19/2011 | CN101947309A Human basic fibroblast growth factor eye drops and preparation method thereof |
| 01/19/2011 | CN101947307A Applications of human placenta peptide in preparing drugs for treating dry eye syndrome and other ocular surface diseases |
| 01/19/2011 | CN101947306A Treatment of T-cell mediated diseases |
| 01/19/2011 | CN101947226A Drops for treating pink eye |
| 01/19/2011 | CN101947218A Method for modulating calcium ion-release-activated calcium ion channels |
| 01/19/2011 | CN101947215A Application of flavonoid compound in tangerine peel to preparation of medicament for inhibiting angiogenesis |
| 01/19/2011 | CN101946986A Nanometer anion fabric seaman body-building working uniform with characteristics of ultra-oleophobic and ultra-hydrophilic properties, antifouling property and self-cleaning property |
| 01/19/2011 | CN101946985A Element fabric health-improving protective clothing capable of killing and repelling mosquitoes |
| 01/19/2011 | CN101627986B Acedofenac-paracetamol pharmaceutical composite and liposome solid preparation thereof |
| 01/19/2011 | CN101591655B PKCalpha signal specifically-blocking siRNA and use thereof |
| 01/19/2011 | CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/19/2011 | CN101209257B Medical use of baicalin and scutellarein derivatives |
| 01/19/2011 | CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 01/19/2011 | CN101014578B Triazole derivative or salt thereof |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 01/18/2011 | US7872129 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
| 01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 01/18/2011 | US7872025 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 01/18/2011 | US7872015 methods for detection, characterization, treatment of neurodegenerative pathologies and identification or screening of compounds such as etazolate in aforementioned pathologies; role of phosphodiesterase 4B, peripheral benzodiazepine receptor (PBR) and GABA receptors of type GABA(A) in these pathologies |
| 01/18/2011 | US7871627 Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation |
| 01/18/2011 | US7871617 Von Willebrand's factor (VWC); transforming growth factors, bone morphongenic proteins as cofactors; monoclonal antibodies for use in diagnosis and treatment of diabetes, hypertension, hyperglycemia and congestive heart failure |
| 01/18/2011 | CA2477769C Ophthalmic composition comprising ascomycin |
| 01/18/2011 | CA2458797C Preparation and diabetic use of gibeberellins |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/18/2011 | CA2432077C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 01/18/2011 | CA2416874C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/18/2011 | CA2368637C Topical treatment or prevention of ocular infections |
| 01/18/2011 | CA2310534C Methods and compositions for treating primary and secondary tumors of the central nervous system (cns) |
| 01/13/2011 | WO2011006079A2 Ophthalmic formulations of reversed liquid crystalline phase materials and methods of using |
| 01/13/2011 | WO2011004733A1 Activity enhancer for oxidized protein hydrolase |
| 01/13/2011 | WO2011003418A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 01/13/2011 | WO2010128486A3 Ophthalmic formulation for the treatment and prevention of pterygium |
| 01/13/2011 | WO2010102031A3 Methods for treating ocular inflammatory diseases |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009488 Lipoxin A4 Protection for Cornea Endothelial Cells |
| 01/13/2011 | US20110009463 Geranylgeranyl transferase inhibitors and methods of making and using the same |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009417 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/13/2011 | US20110009413 Cyclic triazo and diazo sodium channel blockers |
| 01/13/2011 | US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009399 Organic compounds |
| 01/13/2011 | US20110009391 Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application |
| 01/13/2011 | US20110009377 Azetidine derivatives, their preparation and their application in therapy |
| 01/13/2011 | US20110009376 Prophylactic or therapeutic agent for eye disease accompanied by optic nerve disorder |
| 01/13/2011 | US20110009365 Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009339 Method of treating blurred vision and other conditions of the eye with cyclosporin compositions |
| 01/13/2011 | US20110009322 Use of bradykinin and related b2r agonists to treat ocular hypertension and glaucoma |
| 01/13/2011 | US20110009311 Peptides and their utility in modulation of behavior of cells expressing alpha3 beta1 integrins |
| 01/13/2011 | US20110009310 Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation |
| 01/13/2011 | US20110008456 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders |
| 01/13/2011 | US20110008453 Stable Corticosteroid Nanoparticulate Formulations And Methods For The Making And Use Thereof |
| 01/13/2011 | US20110008421 Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye |
| 01/13/2011 | US20110008420 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |
| 01/13/2011 | US20110008419 Vaccine Against Streptococcus Pneumoniae |
| 01/13/2011 | US20110008382 Compositions and methods using recombinant MHC molecules for the treatment of uveitis |
| 01/13/2011 | US20110008340 Anti-properdin antibodies |
| 01/13/2011 | US20110008276 Ethyleneoxide butyleneoxide block copolymer compositions |
| 01/13/2011 | US20110008269 Compositions and Methods Which Modulate G-Protein Signaling for the Treatment of Inflammatory Disorders such as Asthma and Allergic Conjunctivitis |
| 01/13/2011 | CA2767459A1 Ethyleneoxide butyleneoxide block copolymer compositions |
| 01/13/2011 | CA2767079A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |